Table 5_2_2.1
Adult patients with HIV and CD4 count <200 who received Pneumocystis pneumonia (PCP) prophylaxis,a United States, 2003 and 2005
| Population group |
2005 |
2003 |
| Sample size |
Percent |
SE |
Sample size |
Percent |
SE |
| Total |
3,080 |
90.6 |
0.5 |
3,094 |
83.9 |
0.7 |
| Age |
18–44 |
1,853 |
90.8 |
0.7 |
1,907 |
84.2 |
0.8 |
| 45 and over |
1,227 |
90.2 |
0.8 |
1,185 |
83.5 |
1.1 |
| Race |
Non-Hispanic, White |
788 |
91.1 |
1.0 |
828 |
83.5 |
1.3 |
| Non-Hispanic, Black |
1,558 |
90.6 |
0.7 |
1,558 |
83.1 |
1.0 |
| Hispanic |
667 |
90.3 |
1.1 |
655 |
86.4 |
1.3 |
| Other |
43 |
90.7 |
4.5 |
41 |
90.2 |
4.7 |
| Gender |
Male |
2,292 |
91.9 |
0.6 |
2,356 |
84.7 |
0.7 |
| Female |
768 |
86.5 |
1.2 |
738 |
81.4 |
1.4 |
| Health insurance |
Private |
286 |
90.6 |
1.7 |
256 |
81.6 |
2.4 |
| Medicaid/dual eligible |
1,183 |
90.0 |
0.9 |
1,330 |
86.6 |
0.9 |
| Medicare |
493 |
93.3 |
1.1 |
405 |
84.9 |
1.8 |
| Other/uninsured |
566 |
93.3 |
1.1 |
543 |
84.5 |
1.6 |
a For HIV patients having at least two CD4 tests < 200 during the year.
Key: PCP: Pneumocystis pneumonia; SE: standard error.
Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization, and Markets, HIV Research Network.